Unisys Corporation (UIS) Presents at Bank of America Leveraged Finance Conference Transcript

Unisys CFO Debra McCann presented at the BofA Leveraged Finance Conference, positioning the 150-year-old company as a provider of IT solutions with a core 'license and support' business centered on its ClearPath Forward licenses, which she described as a profit and cash generator. The prepared remarks framed the company's long history of transformation and highlighted its license business as a key cash engine, while the transcript cuts off before full detail on the broader services or other business lines.

Analysis

Market structure: Unisys’ emphasis on a high-margin ClearPath license and support business favors legacy-mainframe-dependent customers, niche ISVs and specialist maintenance providers who benefit from sticky recurring revenue; large cloud-native integrators and low-cost offshore services are the losers on migration-resistant workloads. Expect modest pricing power for Unisys on maintenance/licensing renewals (2–5% price increases possible annually) while services revenue remains competitive and lower-margin, pressuring blended margins near-term.

Risk assessment: Tail risks include a large license non-renewal or major client migration to hyperscalers (low-probability, high-impact) and potential covenant pressure if cash conversion lags; watch for liquidity stress within 3–9 months if FCF underperforms guidance. Hidden dependencies: ClearPath revenue cadence and government contract timing create lumpy cash; FX and defense/IT budget cycles are second-order drivers that can flip quarterly results.

Trade implications: Direct equity exposure (UIS) favors small, staged longs with downside protection; credit investors should demand spreads >350–400bps over Treasuries for mid-term bonds given cyclic cash flows. Options trade: cost-efficient bullish exposures (e.g., 6–12 month call spreads) hedge against lumpy earnings while limiting capital at risk; pair trades long UIS / short DXC (DXC) or other broad services names to isolate license-led margin improvement.

Contrarian angles: Consensus underestimates cash resilience from license renewals — a single multi-year ClearPath deal could materially re-rate equity; conversely, market may underprice the risk of client cloud migrations. Historical parallel: legacy software companies that leaned into support revenue (e.g., Oracle in prior cycles) saw re-rating once recurring revenue growth stabilized; watch for similar inflection signals within 2–4 quarters.

Key Decisions for Investors

• Establish a tactical 2–3% long position in Unisys (UIS) equity within 2 weeks, size in tranches (25% now, 25% on a 5–10% pullback, remainder on confirmation of license revenue growth) to capture potential re-rating from ClearPath renewals.
• Implement a hedged options play: buy 6–12 month UIS call spread (buy 12-month 30% OTM call, sell 12-month 60% OTM call) sized to 1–2% portfolio risk to participate in upside while capping premium spent.
• Execute a relative-value pair: long UIS (1–2% notional) and short DXC Technology (DXC) equal-dollar (1–2%) over 3–9 months to isolate margin recovery in license/support vs services commoditization.
• For credit-focused accounts, consider buying UIS senior paper only if spread >350 bps to Treasuries for maturities 2027–2029; otherwise avoid until FCF conversion >8–10% LTM or covenant headroom confirmed.
• Set hard monitoring triggers: add to equity if quarter-over-quarter license & support revenue growth >+5% and operating cash flow turns positive for two consecutive quarters; reduce/exit if license revenue declines >5% QoQ or cash burn exceeds $XMM (replace X with guidance-provided threshold) within 90 days.